Kayla Marsh

664 total citations
7 papers, 43 citations indexed

About

Kayla Marsh is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Kayla Marsh has authored 7 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Kayla Marsh's work include Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Microbial infections and disease research (1 paper). Kayla Marsh is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Microbial infections and disease research (1 paper). Kayla Marsh collaborates with scholars based in Canada, United Kingdom and Australia. Kayla Marsh's co-authors include Alister Craig, Trevor J. Pugh, Chris Newbold, Dax Torti, S Kyes, Philippe L. Bédard, Aaron R. Hansen, Xue Wu, Anna Spreafico and Lisa Wang and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Kayla Marsh

7 papers receiving 43 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kayla Marsh Canada	4	23	22	13	10	8	7	43
Xiaohong R. Yang United States	2	31 1.3×	17 0.8×	6 0.5×	8 0.8×	6 0.8×	3	48
M.A. Rookus Netherlands	4	18 0.8×	23 1.0×	9 0.7×	7 0.7×	3 0.4×	10	70
Helle Kristine Skjerven Norway	4	15 0.7×	18 0.8×	12 0.9×	5 0.5×	6 0.8×	13	46
Joseph McClanaghan United States	4	27 1.2×	13 0.6×	42 3.2×	9 0.9×	4 0.5×	5	59
Misagh Karimi United States	4	10 0.4×	21 1.0×	8 0.6×	5 0.5×	6 0.8×	7	35
Beatriz Rojas Spain	3	11 0.5×	18 0.8×	5 0.4×	7 0.7×	5 0.6×	7	30
Lucía González Cortijo Spain	5	10 0.4×	19 0.9×	13 1.0×	5 0.5×	3 0.4×	11	51
Andrzej Czekański Poland	5	15 0.7×	11 0.5×	19 1.5×	4 0.4×	17 2.1×	7	57
Thomas R Muley Germany	3	12 0.5×	11 0.5×	18 1.4×	18 1.8×	5 0.6×	4	38
Jennifer G. Reeder United States	3	9 0.4×	28 1.3×	18 1.4×	6 0.6×	3 0.4×	4	48

Countries citing papers authored by Kayla Marsh

Since Specialization

Citations

This map shows the geographic impact of Kayla Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayla Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayla Marsh more than expected).

Fields of papers citing papers by Kayla Marsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayla Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayla Marsh. The network helps show where Kayla Marsh may publish in the future.

Co-authorship network of co-authors of Kayla Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Kayla Marsh. A scholar is included among the top collaborators of Kayla Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayla Marsh. Kayla Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wong, Derek, Ping Luo, Arnavaz Danesh, et al.. (2023). Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma. Cancer Research Communications. 3(2). 267–280. 9 indexed citations

2.

Stutheit-Zhao, Eric Y., Zhihui Liu, Kayla Marsh, et al.. (2022). Methylated circulating tumor DNA (cfMeDIP) as a predictive biomarker of clinical outcome in pan-cancer patients (pts) treated with pembrolizumab (P).. Journal of Clinical Oncology. 40(16_suppl). 2550–2550. 5 indexed citations

3.

Araújo, Daniel Vilarim, Ao Wang, Dax Torti, et al.. (2020). Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy. JNCI Cancer Spectrum. 5(3). 16 indexed citations

4.

Araújo, Daniel Vilarim, Dax Torti, Alberto J. León, et al.. (2019). Blood-based TMB (bTMB) correlates with tissue-based TMB (tTMB) in a multi-cancer phase I IO cohort. Annals of Oncology. 30. v512–v512. 1 indexed citations

5.

Weberpals, Johanne I., Trevor J. Pugh, Glenwood D. Goss, et al.. (2018). Tumor molecular profiling to differentiate extreme responses to first-line platinum-based chemotherapy in suboptimally debulked serous ovarian cancer patients.. Journal of Clinical Oncology. 36(15_suppl). 5561–5561. 2 indexed citations

6.

Kyes, S, et al.. (1998). Genomic representation of var gene sequences in Plasmodium falciparum field isolates from different geographic regions (vol 87, pg 235, 1997). Molecular and Biochemical Parasitology. 93. 159–159. 8 indexed citations

7.

Hyde, Katherine, et al.. (1972). CYCLOPHOSPHAMIDE PLUS EMETINE IN LUNG CANCER. The Lancet. 300(7774). 427–427. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact